SYDNEY,Feb. 15,2025--Roborock,a global leader in ultra-intelligent home robotics engineered to simplify daily life,today announces the Australian launch of its newest wet-dry vacuum cleaner range,the
Feb 17, 2025
CAMBRIDGE,Mass.,ROTTERDAM,Netherlands and SHANGHAI,Feb. 14,2025-- HarbourBioMed (the "Company"; HKEX: 02142),a global biopharmaceutical company committed to the discovery,development,and co
Feb 17, 2025
SEOUL,South Korea,Feb. 14,2025--BUYING SQUARE,a next-generation digital wholesale platform,has announced the global launch of Catalog Shop,a B2B solution designed to streamline wholesale transactions
Feb 17, 2025
HONG KONG,Feb. 14,2025-- For the first time,the prestigious five-star international equestrian event with over 50 years of history in London has chosen Hong Kong as its venue,heralding the fruitful Ye
Feb 17, 2025
SHANGHAI and NANJING,China and SAN JOSE,Calif.,Feb. 14,2025-- IASO Biotherapeutics ("IASO Bio"),a biopharmaceutical company focused on the discovery,development,manufacturing,and commerciali
Feb 17, 2025
The media powerhouse is taking over NBA All-Star weekend with exclusive content and star-studded experiences,showcasing a new era for digital entertainment
Feb 17, 2025
HONG KONG,Feb. 14,2025-- On February 14,2025,China Telecom officially announced that the capacity of the Asia Direct Cable (ADC),an international submarine cable initiative led by China Telecom,has be
Feb 17, 2025
XUN COUNTY,China,Feb. 14,2025-- On February 6,2025,the ninth day of the first lunar month,the 17th Central Plains (Hebi) Folk Culture Festival ushered in the Dapishan Temple Fair. The event was a vibr
Feb 17, 2025
XI\'AN,China,Feb. 14,2025-- LONGi has announced the retention of its AAA rating in PV-Tech\'s Q4 2024 PV ModuleTech bankability ratings,marking the company\'s 20th consecutive quarter at this top tie
Feb 17, 2025
This strategic partnership aims to transform professional advisory services by leveraging cutting-edge Generative AI to provide accurate,domain-specific insights
Feb 14, 2025
The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.
Feb 14, 2025
ASEAN Investment Challenge (AIC) 2024 brings together more than 5,000 higher education students for an insightful journey into responsible investing
Feb 14, 2025

© TopicFashion Privacy Policy Contact us